ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626879 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626879; 2) Community: the network communities that were significantly associated with the response to NSC 626879; 3) Molecule: the relationships between components within communities and NSC 626879; 4) MDR: the compounds that were significantly associated with the NSC 626879.

NSC Compound Enrichment Correlation
NSC 625539 Iron, trichloro[phenyl-2-pyridinylmethanone(2-pyridinyl-hydrazonato)]- 0.040397842611974 0.41457263
NSC 669727 Null 0.0490935610249067 0.054060076
NSC 681634 Camptothecin Derivative 0.0490935610249067 0.073385436
NSC 681644 Camptothecin Derivative 0.0490935610249067 0.13942976
NSC 698278 Null 0.0490935610249067 0.38135044
NSC 698394 Piperidine, 1,1'-(3,4-dichloro-2,4-dinitro-1,3-butadiene- 1,1-diyl)bis-, (1Z,3E)- 0.0490935610249067 0.46665652
NSC 72151 2H-1-Benzopyran-2-one, 6-[[4-[bis[2-[(methylsulfonyl)ethyl]amino]phenyl]methylene]amino]- (9CI) 0.0490935610249067 0.015695805
NSC 735332 Null 0.0490935610249067 0.37262108
NSC 146067 cis-Diamminemalonatoplatinum(II) 0.0490935610249068 0.039141469
NSC 174121 Methotrexate Derivative 0.0490935610249068 0.41104835
Total:112  Current:106    [First] [Prev] [Next] [Last]